R. Centis

Publishing 2017

Is this you? Claim this profile
1
Article
135
Reads on Journament
3
Co-authors
1
Journal

This page collects the articles indexed under the name R. Centis. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. rifabutin: is it useful in the treatment of multidrug-resistant tuberculosis?
    S. Tiberi, L. D’Ambrosio, R. Centis, G.B. Migliori
    israel journal of chemistry 2017 135 reads

Possible papers by R. Centis 4

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. applicability of the shorter ‘bangladesh regimen’ in high multidrug-resistant tuberculosis settings
    as Rosella Centis israel journal of chemistry 2017 Istituti Clinici Scientifici Maugeri
    Same journal
  2. MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
    as Rosella Centis International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020
    Same name only
  3. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    as Rosella Centis Lancet (London, England) 2018
    Same name only
  4. Eliminating tuberculosis in Latin America: making it the point
    as Rosella Centis jornal brasileiro de pneumologia 0000
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in